Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:RADCQ)

0.0100 UNCHANGED
Last Price Updated: 9:30 AM EDT, Sep 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about RADCQ

Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Kenvue defends against a consumer lawsuit alleging that its Tylenol "Rapid Release" gelcaps did not relieve pain faster than regular tablets. A federal judge ruled the claims were preempted by FDA... 
Via Benzinga
Topics Lawsuit
Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
JP Morgan Chase is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, aimed at managing the drug-store chain's recently downgraded near-term... 
Via Benzinga
Topics Bonds
3 Cybersecurity Stocks That Could Be Multibaggers in the Making: July Edition
When it comes to cyber threats, we’re sitting ducks, which creates more opportunity for leading cybersecurity stocks. 
Via InvestorPlace
CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lenders. Following Chapter 11 bankruptcy and $750 million in losses, the pharmacy... 
Via Benzinga
Topics Bankruptcy
Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Major US pharma chain Walgreens to close undisclosed number of stores due to headwinds, CEO acknowledges challenges. Rite Aid also faces bankruptcy. 
Via Benzinga
Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
MedImpact's bid to reclaim $200 million after acquiring Rite Aid's pharmacy benefits unit has failed. U.S. Bankruptcy Judge ruled MedImpact assumed Elixir's debts in the $575 million deal. 
Via Benzinga
Topics Bankruptcy
Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement,... 
Via Benzinga
Topics Bankruptcy
Short-Sell Candidates: 3 Vastly Overvalued Stocks Ripe for Shorting
After stocks rallied, many stocks became overvalued, creating an opportunity for investors to profit through short selling. 
Via InvestorPlace
Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records with law enforcement. 
Via Benzinga
Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring
Rite Aid Corp (OTC: RADCQ), currently undergoing bankruptcy proceedings, has reportedly taken a legal stance against the U.S. 
Via Benzinga
Topics Bankruptcy Lawsuit
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a  
Via Benzinga
7 Blue-Chip Stocks to Sell and Never Buy Back
Investors would be smart to part ways with these troubled blue-chip stocks to sell, each of which has seen its share price erode. 
Via InvestorPlace
WeBroke: Investors Must Avoid WE Stock if It Trades Again
WeWork just filed for bankruptcy. If WE stock starts trading again, investors should stay away at all costs. 
Via InvestorPlace
Topics Bankruptcy
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
Workers at pharmacy companies CVS, Walgreens and RiteAid have staged a three-day strike over unsafe and poor working conditions. 
Via InvestorPlace
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
GSK (NYSE: GSK) has reportedly taken an early lead in the race for respiratory syncytial virus (RSV) vaccine dominance, surpassing Pfizer Inc (NYSE: PFE), which previously dominated the COVID-19... 
Via Benzinga
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
Beginning Monday, pharmacy employees from leading chains such as CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance, Inc. (NASDAQ: WBA), and Rite Aid Corp (OTC: 
Via Benzinga
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
On Friday, the FDA issued a warning to consumers, cautioning them against the use of certain over-the-coun 
Via Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
The U.S. 
Via Benzinga
3 High-Yield Stocks for Long-Term Income
These three high-yield stocks are enticing picks for income investors looking for safety and long-term growth. 
Via InvestorPlace
WBA Stock Jumps On Upgrade, Target Hike. New CEO, 'New Era' Analyst Says
JPMorgan expects Walgreens' new CEO to usher in "a new era" for the Dow Jones giant. 
Via Investor's Business Daily
Topics Stocks
Make Rite Aid a Meme Stock at Your Own Risk
After declaring bankruptcy, Rite Aid has surged on meme stock momentum. Here's why that still doesn't make it a buy. 
Via InvestorPlace
Topics Bankruptcy
Walgreens Agrees To Pay $192.5M To Resolve Rite Aid Buyout Suit: Report
Walgreens Boots Alliance Inc (NASDAQ: WBA) has reportedly consented to a settlement of $192.5 million following allegations that some of the company's executives provided misleading information... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.